Study open
Supernova
The purpose of this study is to demonstrate the safety and efficacy of this product to prevent COVID 19. These results were already shown by previous studies with a small target group. This study will include the group between 12 and 18 years of age. The two active vaccines will be compared with each other in combination with a minimal placebo group. Would you like to help science also strengthen people with impaired immunity in fighting COVID-19?
At Anima, each study is preceded by a screening interview where you will have the opportunity to discuss with the doctor any further questions or uncertainties in a discreet manner.
Participation in the study
- 95% chance of getting one of the 2 variants administered
- <5 % kans dat je een placebo krijgt
Target
- Are you a boy/girl older than 12 years (weigh more than 40kg)
- Are you a male/female over 18 years of age
- Do you have immunity problems owing to your cancer treatment, transplants, rheumatism, psoriasis, ...
Program
- The study lasts a maximum of 12 months
- You will need to come to the study center at least 11 times during this period.
- There will be a weekly follow-up by phone or email
Location
Anima Research Center
Alkerstraat 32Z (Block D)
3570 Alken
Belgium
Reimbursement
You will receive a fee to compensate for the time and actions.